| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 |
| filingDate |
1994-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a737c96029dfec35112903bda27639f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_810d4622159ea89d8eb3fdef3203c97a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37fc82448883e887cf7ccd2c037293bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76fe97b1895c8ccddf9a076eef4b58f3 |
| publicationDate |
1997-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
HU-T74616-A |
| titleOfInvention |
Agent, intended for transdermal administration, containing 14alfa, 17alfa-ethanoestra-1,3,5(10)-triene-3,17beta-diol |
| abstract |
The present invention relates to an agent for transdermal administration which optionally comprises one or two gestagen-olefin phosphorus 14a, 17a-ethanyltra-1,3,5 (10) thio-3,17-diol. Ü 2 TJ |
| priorityDate |
1994-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |